Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Toxicol Mech Methods ; 24(5): 362-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24720789

ABSTRACT

4-Hydroxynonenal (HNE), a diffusible aldehyde product of membrane lipid peroxidation, can be produced by oxidative stress and has been detected in several diseases such as diabetes. In this study, we investigated the effects of HNE exposure on cytotoxicity, intracellular redox status, endoplasmic reticulum (ER) stress and apoptosis in insulinoma cell line (INS-1). Short-term (1 h) incubation of INS-1 cells with 0-50 µM HNE decreased cell viability and caused depletion in reduced glutathione (GSH) levels and increased intracellular HNE-histidine adducts in a concentration-dependent manner. HNE activated the ER stress, leading to an increase in inositol-requiring enzyme-1a IRE1-α, phosphorylation of protein kinase-like ER kinase, phosphorylation of c-Jun N-terminal kinase (JNK) and increased the expression of CCAAT/enhancer binding protein (CHOP). Western blot analysis showed that HNE exposure induced dose-dependent activation of caspase 9 and caspase 3. These data indicate a potential role for HNE promoting deleterious effects toward pancreatic beta cell redox status and beta cell mass which may be important for the pathogenesis in diabetes.


Subject(s)
Aldehydes/toxicity , Apoptosis/drug effects , Endoplasmic Reticulum Stress/drug effects , Insulin-Secreting Cells/drug effects , Animals , Caspases/metabolism , Glutathione/metabolism , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , Oxidation-Reduction , Rats , Tumor Cells, Cultured
2.
Acta Biochim Pol ; 60(3): 451-6, 2013.
Article in English | MEDLINE | ID: mdl-24020061

ABSTRACT

Intravenous lipopolysaccharide (LPS) leads to acute lung injury (ALI) in rats. The purpose of this study was to examine the anti-inflammatory and antioxidant efficacy of ketamine, propofol, and ketofol in a rat model of ALI. We induced ALI in rats via intravenous injection of LPS (15 mg kg(-1)). The animals were randomly separated into five groups: control, LPS only, LPS + ketamine (10 mg·kg(-1)·h(-1)), LPS + propofol (10 mg·kg(-1)·h(-1)), LPS + ketofol (5 mg·kg(-1)·h(-1) ketamine + 5 mg·kg(-1)·h(-1) propofol). LPS resulted in an increase in the release of pro-inflammatory cytokines, mRNA expression related with inflammation, production of nitric oxide, and lipid peroxidation. Ketamine prevented the increase in markers of oxidative stress and inflammation mediators, both in plasma and lung tissue. Propofol decreased the levels of cytokines in plasma and lung tissue, whereas it had no effect on the IL-1-beta level in lung tissue. Ketamine downregulated mediators of lung tissue inflammation and reduced the level of circulating cytokines and protected lung tissue against lipid peroxidation. Ketofol decreased the level of TNF-α and IL-1ß in plasma, as well as expression of cyclooxygenase-2 mRNA and the nitrate/nitrite level in lung tissue. The results of this investigation support the hypothesis that ketamine may be effective in preventing ALI.


Subject(s)
Acute Lung Injury/prevention & control , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Endotoxemia/prevention & control , Ketamine/pharmacology , Lung/drug effects , Propofol/pharmacology , Acute Lung Injury/chemically induced , Acute Lung Injury/metabolism , Acute Lung Injury/pathology , Administration, Intravenous , Animals , Biomarkers/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Drug Combinations , Endotoxemia/chemically induced , Endotoxemia/metabolism , Endotoxemia/pathology , Female , Gene Expression , Interleukin-1beta/antagonists & inhibitors , Interleukin-1beta/biosynthesis , Lipid Peroxidation/drug effects , Lipopolysaccharides , Lung/metabolism , Lung/pathology , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/biosynthesis , Oxidative Stress/drug effects , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/biosynthesis
3.
J Med Food ; 15(4): 391-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22191573

ABSTRACT

Changes in vascular endothelial growth factor (VEGF), angiotensin-converting enzyme (ACE), matrix metalloproteinase (MMP)-9, and endothelial nitric oxide synthase (eNOS) mRNA expression profiles and oxidative stress in the eye tissue microenviroment may have important roles in ocular neovascularization and permeability in proliferative diabetic retinopathy. The present study investigated the effects of resveratrol (RSV) treatment on the mRNA expression profile of VEGF, ACE, MMP-9, and eNOS, which are associated with vascular neovascularization, and glutathione, protein carbonyl, and nitrite-nitrate levels, which are markers of oxidative stress in eyes of diabetic rats. Twenty-four Wistar albino male rats were divided into four groups. After diabetes induction with streptozotocin (10 mg/kg/day) RSV was administered to the RSV and diabetes mellitus (DM) + RSV groups for 4 weeks. The mRNA levels were measured by quantitative real-time polymerase chain reaction assay, and biochemical estimations were determined with spectrophotometric assays in eye homogenates. The mRNA expression levels of VEGF, ACE, and MMP-9 were increased in the DM group compared with the control group, and RSV treatment decreased their mRNA levels. Expression of eNOS mRNA was increased in the RSV and DM groups and decreased in the DM + RSV group. Nitrite-nitrate levels and protein carbonyl content were increased and glutathione levels were decreased in the DM group compared with controls. Consequently, these data suggest that RSV suppressed the expression of eNOS, which is actively involved in the inflammation and healing process in chronic diabetes. Although oxidative stress was increased in eye tissue from diabetic rats, mRNA levels of VEGF, MMP-9, and ACE genes associated with vascular remodeling did not change in diabetic eyes.


Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/pathology , Oxidative Stress , Stilbenes/administration & dosage , Angiotensin-Converting Enzyme 2 , Animals , Diabetic Retinopathy/pathology , Eye/drug effects , Eye/pathology , Male , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Nitrates/analysis , Nitric Oxide Synthase Type III/genetics , Nitric Oxide Synthase Type III/metabolism , Nitrites/analysis , Peptidyl-Dipeptidase A/genetics , Peptidyl-Dipeptidase A/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Resveratrol , Streptozocin/adverse effects , Streptozocin/metabolism , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
4.
Mol Cell Biochem ; 347(1-2): 41-51, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20936496

ABSTRACT

Human epidermal growth factor receptor 2 (ErbB2) amplification and overexpression has been seen in many cancer types including non-small cell lung cancer (NSCLC). Thus, ErbB2 is an important target for cancer therapies. Increased ErbB2 expression has been associated with drug resistance in cancer cells. Herceptin is a humanized monoclonal antibody that targets the extracellular domain of ErbB2. In this study, we aimed to block ErbB2 signaling with Herceptin and assess cytotoxicity and effects on apoptosis, oxidative stress, nuclear factor kappa-B (NF-kB), and Survivin expression in Calu-3 cell line. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay were used to assess cell viability as a marker of proliferation. Acridine orange/ethidium bromide (AO/EB) staining and caspase 3/7 activity were measured as the markers of apoptosis. The relative expressions of NF-kB-p50 and Survivin mRNAs were evaluated. Activities of antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT), and the levels of glutathione (GSH) and reactive oxygen species (ROS) were determined in a time- and dose-dependent manner. Our results show that Herceptin treatment inhibits cell proliferation and activates apoptosis but without effects on Survivin and NF-kB expression in Calu-3 cell line. Intracellular glutathione levels and SOD and CAT activities were decreased in a time- and dose-dependent manner associated with oxidative stress. Also, ROS were increased at 24 h. These results provide evidence that Herceptin can be used as a cytotoxic and apoptotic agent in NSCLC.


Subject(s)
Antibodies, Monoclonal/pharmacology , Apoptosis/drug effects , Oxidative Stress/drug effects , Receptor, ErbB-2/antagonists & inhibitors , Antibodies, Monoclonal, Humanized , Antioxidants/metabolism , Caspase 3/metabolism , Caspase 7/metabolism , Catalase/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Gene Expression Regulation, Neoplastic/drug effects , Glutathione/metabolism , Humans , Inhibitor of Apoptosis Proteins , Intracellular Space/drug effects , Intracellular Space/metabolism , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , NF-kappa B p50 Subunit/genetics , NF-kappa B p50 Subunit/metabolism , Necrosis , Reactive Oxygen Species/metabolism , Receptor, ErbB-2/metabolism , Superoxide Dismutase/metabolism , Survivin , Time Factors , Trastuzumab
5.
Eur J Pharmacol ; 654(1): 80-5, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21172345

ABSTRACT

One of the main goals of treatment of diabetes mellitus is to prevent its complications. Oxidative stress is universal in diabetes, being ultimately involved with the development complications. As a result of hyperglycemia, reactive oxygen/nitrogen species are produced in various tissues that leads to tissue damage with lipid peroxidation and protein oxidation, along with disruption in cellular homeostasis and accumulation of damaged molecules. Hence, supplementation with antioxidant compounds may offer some protection against diabetic complications. The pleiotropic effects of statins, including antioxidant and anti-inflammatory properties, represent an area of great interest in prevention and therapy of cardiovascular and neurological disorders. Using biomarkers of oxidative stress, in this study we examined the effect of non cholesterol lowering dose, long term fluvastatin treatment on oxidative stress in streptozotocin-diabetic rats. Experiments were conducted in 24 Wistar adult male rats. Diabetic and non-diabetic rats were treated orally for 6 months with fluvastatin (2mg/kg/day, p.o) starting one week after streptozotocin injection (55 mg/kg, i.p.), (preventive study). In brain, heart, liver, pancreas and kidney homogenates malondialdehyde, lipid hydroperoxide, protein carbonyl content, advanced oxidation protein products, 3-nitrotyrosine levels and superoxide dismutase, catalase activities were measured. Hyperglycemia and dyslipidemia in diabetic groups remained unchanged after fluvastatin treatment. The drug act as antioxidant in the tissues. Hence, antioxidant property of fluvastatin, independent of cholesterol lowering effect, may play a role in prevention of diabetic complications. Clinical relevance of this effect of fluvastatin seems worthy of further studies.


Subject(s)
Antioxidants/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Fatty Acids, Monounsaturated/pharmacology , Indoles/pharmacology , Oxidative Stress/drug effects , Administration, Oral , Animals , Antioxidants/administration & dosage , Biomarkers/metabolism , Brain/metabolism , Diabetes Mellitus, Experimental/physiopathology , Fatty Acids, Monounsaturated/administration & dosage , Fluvastatin , Indoles/administration & dosage , Male , Rats , Rats, Wistar , Streptozocin
6.
Neuro Endocrinol Lett ; 31(3): 313-8, 2010.
Article in English | MEDLINE | ID: mdl-20588243

ABSTRACT

OBJECTIVES: Recent basic research and clinical data have provided new insights into the role of glycoxidative and nitrosative stresses (both oxidative stress) in diabetic complications, such as diabetic nephropathy, suggesting a different and innovative approach to antioxidant therapy. In streptozotocin-induced diabetic rat kidney, the present study investigated the effects of the synthetic pyridoindole antioxidant stobadine (STB) on renal total antioxidant potential (AOP) and protein oxidation parameters such as protein carbonyl content (PCC), advanced oxidation protein products (AOPPs) and nitrotyrosine (NT), a marker specific for protein modification by peroxynitrite. MATERIALS AND METHODS: Wistar Albino rats were divided into two groups: normal and streptozotocin-induced diabetic rats. Each group of the animals was further divided into two groups: untreated and treated with stobadine (24.7 mg/kg) during 16 weeks daily by oral gavage. RESULTS: The renal tissue AOP and the levels of AOPPs, PCC and NT were increased in diabetic rats compared with the untreated control animals. Furthermore, stobadine treatment significantly decreased protein carbonylation and AOPPs but not NT. CONCLUSIONS: These findings indicate that STB is an antioxidant factor which can improve glycoxidative stress markers in kidney, while it has no effect on protein nitrosylation.


Subject(s)
Antioxidants/pharmacology , Carbolines/pharmacology , Diabetes Mellitus, Experimental/metabolism , Glycation End Products, Advanced/metabolism , Kidney/drug effects , Oxidative Stress/drug effects , Protein Carbonylation/drug effects , Tyrosine/analogs & derivatives , Animals , Antioxidants/therapeutic use , Blood Glucose/drug effects , Body Weight/drug effects , Carbolines/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Kidney/metabolism , Male , Rats , Rats, Wistar , Tyrosine/metabolism
7.
Urology ; 76(2): 508.e1-5, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20510442

ABSTRACT

OBJECTIVES: To investigate the involvement of oxidative stress in the pathogenesis of acute pyelonephritis, and to evaluate the impact of meloxicam and/or L-carnitine in addition to conventional antibiotic treatment. METHODS: A total of 48 Wistar rats were divided into 4 groups according to their treatment, which was started 1 day after inoculation of all rats with Escherichia coli (ATCC 25 922, 10(10) cfu/mL). Group 1 received only antibiotic treatment with ceftriaxone (50 mg/kg, IM). Groups 2 and 3 received L-carnitine (500 mg/kg, IM) and meloxicam (3 mg/kg, IM) in addition to conventional treatment, respectively. Group 4 received combination therapy (L-carnitine and meloxicam) in addition to the first group. Rats were killed 3 and 7 days after E. coli inoculation and underwent nephrectomy. Histologic determination of tubular atrophy, acute and chronic inflammation, interstitial fibrosis and biochemical determination of superoxide dismutase and catalase activity, total thiol content, total antioxidant capacity, and malondialdehyde and protein hydroperoxide levels were measured. RESULTS: Interstitial fibrosis (P = .06), chronic inflammation (P = .536), and tubular atrophy (P = 0.094) decreased in group 4 compared with the other groups, but there was a statistically significant decrease only in acute inflammation (P = .015). In addition, if the day of nephrectomy is considered, there was again a significant decrease in acute inflammation on day 7 compared with day 3 in groups 2, 3, and 4 (P = .002). Catalase significantly increased in group 2 (P = .029), group 3 (P = .02), and group 4 (P = .014), and decreased in group 1 (P = .012) in day 7. CONCLUSIONS: L-carnitine and meloxicam alleviated oxidative stress, probably by decreasing lipid peroxidation and enforcing antioxidant defense system. Acute renal inflammatory injury can be prevented much more effectively by combination therapy rather than by conventional therapy alone.


Subject(s)
Antioxidants/physiology , Carnitine/therapeutic use , Cyclooxygenase 2 Inhibitors/therapeutic use , Oxidative Stress , Pyelonephritis/drug therapy , Pyelonephritis/etiology , Thiazines/therapeutic use , Thiazoles/therapeutic use , Animals , Anti-Bacterial Agents/therapeutic use , Drug Therapy, Combination , Male , Meloxicam , Rats , Rats, Wistar
8.
World J Gastroenterol ; 13(21): 2932-8, 2007 Jun 07.
Article in English | MEDLINE | ID: mdl-17589942

ABSTRACT

AIM: To determine the effect of exogenous leptin on acute lung injury (ALI) in cerulein-induced acute pancreatitis (AP). METHODS: Forty-eight rats were randomly divided into 3 groups. AP was induced by intraperitoneal (i.p.) injection of cerulein (50 microg/kg) four times, at 1 h intervals. The rats received a single i.p. injection of 10 mug/kg leptin (leptin group) or 2 mL saline (AP group) after cerulein injections. In the sham group, animals were given a single i.p. injection of 2 mL saline. Experimental samples were collected for biochemical and histological evaluations at 24 h and 48 h after the induction of AP or saline administration. Blood samples were obtained for the determination of amylase, lipase, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, macrophage inflammatory peptide (MIP)-2 and soluble intercellular adhesion molecule (sICAM)-1 levels, while pancreatic and lung tissues were removed for myeloperoxidase (MPO) activity, nitric oxide (NOx) level, CD40 expression and histological evaluation. RESULTS: Cerulein injection caused severe AP, confirmed by an increase in serum amylase and lipase levels, histopathological findings of severe AP, and pancreatic MPO activity, compared to the values obtained in the sham group. In the leptin group, serum levels of MIP-2, sICMA-1, TNF-alpha, and IL-1beta, pancreatic MPO activity, CD40 expression in pancreas and lung tissues, and NOx level in the lung tissue were lower compared to those in the AP group. Histologically, pancreatic and lung damage was less severe following leptin administration. CONCLUSION: Exogenous leptin attenuates inflamma-tory changes, and reduces pro-inflammatory cytokines, nitric oxide levels, and CD40 expression in cerulein-induced AP and may be protective in AP associated ALI.


Subject(s)
Leptin/therapeutic use , Pancreatitis/complications , Respiratory Distress Syndrome/drug therapy , Respiratory Distress Syndrome/etiology , Acute Disease , Animals , CD40 Antigens/metabolism , Ceruletide , Chemokine CXCL2 , Chemokines, CXC/blood , Female , Interleukin-1beta/blood , Lung/metabolism , Lung/pathology , Nitric Oxide/metabolism , Pancreas/metabolism , Pancreas/pathology , Pancreatitis/chemically induced , Peroxidase/metabolism , Random Allocation , Rats , Rats, Wistar , Respiratory Distress Syndrome/metabolism , Tumor Necrosis Factor-alpha/blood
9.
J Med Syst ; 29(6): 679-708, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16235821

ABSTRACT

The aim of this study is to determine lipid peroxidation and antioxidant enzyme levels in spleen and testis tissues of guinea pigs which were exposed to different intensities and periods of DC (direct current) and AC (alternating current) electric fields. The experimental results are applied to neural networks as learning data and the training of the feed forward neural network is realized. At the end of this training; without applying electric field to the tissues, the determination of the effects of the electric field on tissues by using computer is predicted by the neural network. After the experiments, the prediction of the neural network is averagely 99%.


Subject(s)
Electromagnetic Fields/adverse effects , Neural Networks, Computer , Animals , Guinea Pigs , Lipid Peroxidation , Male , Malondialdehyde/analysis , Spleen/metabolism , Spleen/radiation effects , Superoxide Dismutase/analysis , Testis/metabolism , Testis/radiation effects
10.
Article in English | MEDLINE | ID: mdl-15172678

ABSTRACT

Iloprost, a stable analogue of prostacyclin, was used to reverse the early period of vasoconstriction provoked by Endothelin-1 by administering into the rabbit basilar artery. We observed if this produced an effect on the central nervous system parenchyma mediated by free radical system. The red neurons were counted in brain stem sections stained with haematoxylin and eosin, while superoxide dismutase and malondialdehyde levels were measured in brain stem tissue samples as a marker of reactive oxygen metabolites; both 30 and 90 min after administration of either Endothelin-1 (0.25 ng) alone or Endothelin-1 followed by Iloprost (0.5 microg/kg) into the basilar artery. Endothelin-1 significantly increased the number of red neurons, while Iloprost significantly reduced them after 30 and 90 min. However, regarding the reactive oxygen metabolites; a similar reversing effect of Iloprost was not observed although superoxide dismutase levels were significantly decreased after Endothelin-1 infusion.


Subject(s)
Brain Stem/metabolism , Endothelin-1/administration & dosage , Free Radicals/metabolism , Iloprost/administration & dosage , Vasoconstriction/drug effects , Vasodilator Agents/administration & dosage , Animals , Basilar Artery , Brain Chemistry , Injections, Intra-Arterial , Malondialdehyde/analysis , Neurons/metabolism , Rabbits , Superoxide Dismutase/analysis
11.
Photodermatol Photoimmunol Photomed ; 18(3): 117-20, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12207673

ABSTRACT

BACKGROUND/PURPOSE: Free oxygen radicals are involved in inflammatory skin reactions induced by ultraviolet B (UVB). In this study, the effect of a herbal antioxidant Ginkgo biloba extract (EGb 761) was investigated in UVB irradiated mice skin. METHODS: The study was carried out on four groups of mice (n = 6 in each group). The first group was a control group (G1). The second group (G2) was only exposed to acute UVB irradiation. The third group (G3) received 100 mg/kg/day of EGb 761 orally for 5 days before UVB irradiation and the fourth group (G4) was given only a single dose of EGb 761 immediately after UVB irradiation. Eighteen hours after exposing to UVB, lipid peroxide levels, and superoxide dismutase (SOD) activities were studied and UVB damage was evaluated histopathologically according to "sun-burn cell count". RESULTS: The SOD activities and Malondialdehyde (MDA) levels in G2, G3 and G4 were found to be decreased significantly when compared with G1 (P < 0.05). The SOD activities of G3 and G4 were higher when compared with G2 (P < 0.05). The number of sunburn cells (SBCs) was the highest in G2. CONCLUSIONS: Our results suggest that EGb 761 may have an important effect, both as a protective and therapeutic agent, in sunburn after UVB irradiation.


Subject(s)
Lipid Peroxides/metabolism , Plant Extracts/pharmacology , Sunburn/metabolism , Sunburn/prevention & control , Superoxide Dismutase/metabolism , Ultraviolet Rays/adverse effects , Analysis of Variance , Animals , Free Radicals , Ginkgo biloba , Lipid Peroxidation , Male , Malondialdehyde/metabolism , Mice , Mice, Inbred BALB C , Sunburn/enzymology
12.
Cell Biochem Funct ; 20(2): 103-5, 2002 Jun.
Article in English | MEDLINE | ID: mdl-11979505

ABSTRACT

Several recent studies have revealed a wide role for nitric oxide (NO) in bone metabolism. Low doses of NO cause bone resorption, but higher doses of NO inhibit bone resorbing activity. Cytokines are potent stimulators of NO production. NO is a very short-lived molecules. It exists for only 6-10 s only before it is converted by oxygen and water into the end-products nitrates and nitrites. Osteoporosis is a metabolic bone disease, characterized by a decreased amount of bone and increased susceptibility to fracture. NO may be involved as a mediator of bone disease such as post-menopausal osteoporosis. Calcitonin is a peptide hormone that inhibits bone resorption. The function of calcitonin in some cells is often unclear. In this study 30 post-menopausal osteoporotic women of ages ranging between 55 and 59 years without systemic diseases and free of any drug therapy were included. Twenty of them, randomly chosen, were treated with calcium (500 mg day(-1))+calcitonin (nasal spray 100 U day(-1)) and the other 10 women (control group) were treated with calcium only. This treatment was applied for 6 months and NO values were measured in each of the two groups before and after treatment. Our findings demonstrate that NO regulates osteoclastic bone resorption activity in association with calcitonin.


Subject(s)
Calcitonin/pharmacology , Nitric Oxide/blood , Osteoporosis, Postmenopausal/blood , Calcium/therapeutic use , Drug Therapy, Combination , Female , Humans , Middle Aged , Nitric Oxide/physiology , Osteoporosis, Postmenopausal/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...